Navigation Links
PETA International Science Consortium disappointed in denial of Dow appeal
Date:6/19/2013

The PETA International Science Consortium (PISC) is extremely disappointed that the European Chemicals Agency (ECHA) Board of Appeal has upheld a decision that requires Dow Benelux B.V.to conduct a pre-natal developmental toxicity study in rats. The study will use approximately 1160 animals and expose pregnant rats and their unborn pups to the substance dipropylene glycol methyl ether acetate (DPMA) in order to comply with the European Community's Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).

PISC urges the Board of Appeal to demonstrate greater independence when making decisions regarding the justification of read-across arguments in future appeal cases.

The substance DPMA hydrolyses to dipropylene glycol methyl ether (DPM), for which data are already available. In an appeal filed on January 24, 2012, the company rightfully argued that the testing requirement was, therefore, satisfied using read-across arguments.

The Board of Appeal's decision means that pregnant rats will be forced to consume high concentrations of the chemical over a 16 day period before being killed and their offspring, dissected. Read-across arguments are a mechanism by which large numbers of animal tests can be avoided which makes this decision even more disappointing as it may unjustifiably discourage other chemical manufacturers from using valid read-across arguments which could ultimately lead to hundreds of thousands of additional animals being used. As many as ten million animals could be used in testing conducted for REACH.

The European Ombudsman is currently considering a complaint submitted by PETA in July 2012 alleging that ECHA is failing to ensure that animal testing is conducted only as a "last resort," as required by the REACH regulation.


'/>"/>

Contact: Gilly Stoddart
GillyS@peta.org.uk
44-207-837-6327
People for the Ethical Treatment of Animals
Source:Eurekalert

Page: 1

Related biology news :

1. First international collaboration to showcase latest body of evidence of dairy health benefits
2. SPIE on global team proposing International Year of Light at United Nations
3. CLEO: 2013 -- the Premier International Laser and Electro-Optics Event in San Jose next week
4. New review sets international standards for best practice in fracture liaison services
5. BGI hosts its 2nd International Conference on Genomics in the Americas
6. Drive-Up Biometric System from SRI International Sarnoff Wins New Product Showcase Award at ISC West 2013
7. International conference will put agri-food supply chain under the microscope
8. International collaboration to investigate disappearing reptiles and amphibians
9. International conference to tackle climate-change threats to agriculture
10. International study: Excess dietary salt may drive the development of autoimmune diseases
11. International consortium builds Google Map of human metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: